Baboon syndrome resulting from systemic drugs: Is there strife between SDRIFE and allergic contact dermatitis syndrome?

Contact Dermatitis

Volumn 51, Issue 5-6, 2004, Pages 297-310

  Hausermann P ^a   Harr, Th ^a   Bircher, A J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Allergic contact dermatitis syndrome; Baboon syndrome; Systemic contact dermatitis

Indexed keywords

ALLOPURINOL; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BARIUM SULFATE; CEFALEXIN; CEFTRIAXONE; CEFUROXIME; CIMETIDINE; CLINDAMYCIN; ERYTHROMYCIN; HEPARIN; HUMAN IMMUNOGLOBULIN; HYDROXYUREA; MITOMYCIN C; NAPROXEN; NYSTATIN; OXYCODONE; PENICILLIN V; PIVAMPICILLIN; PSEUDOEPHEDRINE; ROXITHROMYCIN; SALSALATE; TERBINAFINE;

ADULT; AGED; ARTICLE; BABOON SYNDROME; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG ERUPTION; ERYTHEMA; FEMALE; GLUTEUS MAXIMUS MUSCLE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SKIN ALLERGY;

ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; BUTTOCKS; CEFUROXIME; DERMATITIS, ALLERGIC CONTACT; DRUG ERUPTIONS; ERYTHEMA; FEMALE; HUMANS; INTERTRIGO; LEG DERMATOSES; MALE; SYNDROME; THIGH;

EID: 11144300225     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-1873.2004.00445.x     Document Type: Article

References (47)

1. Andersen K E, Hjorth N, Menné T. The baboon syndrome: systemically-induced allergic contact dermatitis. Contact Dermatitis 1984: 10: 97-100.
2. Nakayama H, Niki F, Shono M, Hada S. Mercury exanthema. Contact Dermatitis 1983: 9: 411-417.
3. Menné T, Veien N K, Maibach H L. Systemic contact dermatitis. Am J Contact Dermat 1994: 5: 1-12.
4. Lachapelle J M. The spectrum of diseases for which patch testing is recommended. Patients who should be investigated. In: Patch Testing/Prick Testing. A Practical Guide, Lachapelle J M, Maibach H I (eds): Berlin, Springer Verlag, 2003: 189, pp.7-26.
5. Shelley W B, Shelley E D. Nonpigmenting fixed drug eruption as a distinctive reaction pattern: examples caused by sensitivity to pseudoephedrine hydrochloride and tetrahydrozoline. J Am Acad Dermatol 1987: 17: 403-407.
6. Sanchez T S, Sanchez-Perez J, Aragues M, Garcia-Diaz A. Flare-up reaction of pseudoephedrine baboon syndrome positive patch test. Contact Dermatitis 2000: 42: 312-313.
7. Sanchez-Morillas L, Reano Marios M, Rodriguez Mosquera M et al. Baboon syndrome due to pseudoephedrine. Contact Dermatitis 2003: 48: 234.
8. Lerch M, Bircher A J. Systemically induced exanthem from mercury. Contact Dermatitis 2004: 50: 349-353.
9. Wolf R, Brenner S, Krakowski A. Intertriginous drug eruption. Acta Derm Venereol 1992: 72: 441-442.
10. Montag G, Weber L, Gall H. Baboon-syndrom auf Allopurinol. Akt Dermatol 1996: 22: 311-313.
11. Garcia-Bravo B, Repiso J B, Camacho F. Systemic contact dermatitis due to deflazacort. Contact Dermatitis 2000: 43: 359-360.
12. Stubb S, Alonko K, Reitamo S. Fixed drug eruption: 77 cases from 1981 to 1985. Br J Dermatol 1989: 120: 583.
13. Roujeau J C, Bioulac-Sage P, Bourseau C et al. Acute generalized exanthemtous pustulosis. Analysis of 63 cases. Arch Dermatol 1991: 127: 8.
14. Britschgi M, Steiner U C, Schmid S et al. T-cell involvement in drug-induced acute generalized exanthemtous pustulosis. J Clin Invest 2001: 107: 1433-1441.
15. Bocquet H, Bagot M, Roujeau J C. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996: 15: 250-257.
16. Wolf R, Brenner S, Ruocco V, Filioli F G. Isotopic response. Int J Dermatol 1995: 34: 341-348.
17. Wolf R, Orion E, Matz H. The baboon syndrome or intertriginous drug eruption: a report of eleven cases and a second look at its pathomechanism. Dermatol Online J 2003: 9: 2.
18. Herfs H, Schirren C G, Przybilla B, Plewig G. Baboon syndrome. A particular manifestation of hematogenous contact reaction. Hautarzt 1993: 44: 466-469.
19. Duve S, Worret W, Hofmann H. The baboon syndrome: a manifestation of hematogenous contact-type dermatitis. Acta Derm Venereol 1994: 76: 480-481.
20. Kohler L D, Schonlein K, Kautzky F, Vogt H J. Diagnosis at first glance: the baboon syndrome. Int J Dermatol 1996: 35: 502-503.
21. Wakelin S H, Sidhu S, Orton DI et al. Amoxycillin-induced flexural exanthem. Clin Exp Dermatol 1999: 24: 71-73.
22. Kick G, Przybilla B. Delayed prick test reaction identifies amoxicillin as elicitating baboon syndrome. Contact Dermatitis 2000: 43: 366-367.
23. Loze I, Milpied-Homsi B, Parent E, Stalder J F. Le syndrome babouin, une toxidermie particulière: quatre observations. Nouv Dermatol 2001: 20: 624-625.
24. Strub C, Bircher A J. Exanthem with emphasis of body flexure points 10 hours after administration of amoxicillin, 'baboon syndrome. Schweiz Rundsch Med Prax 2002: 91: 232-234.
25. Schultz E S, Diepgen T L. Clinical characteristics and the causes of the baboon Syndrome. Dermatosen 1996: 44: 266-269.
26. Rasmussen L P, Menné T. Systemic contact eczema in ampicillin allergy. Ugeskr Laeger 1995: 147: 1341-1342.
27. Wolf R, Elman M, Brenner S. Drug-induced 'intertrigo'. Int J Dermatol 1993: 32: 515-516.
28. Goossens C, Sass U, Song M. Baboon syndrome. Dermatology 1997: 194: 421-422.
29. Panhans-Gross A, Gall H, Peter R U. Baboon syndrome after oral penicillin. Contact Dermatitis 1999: 41: 352-353.
30. Amichai B, Grunwald M H. Baboon syndrome following oral roxithromycin. Clin Exp Dermatol 2002: 27: 523.
31. Helmbold P, Hegemann B, Dickert C, Marsch W C. Symmetric ptychotropic and nonpigmenting fixed drug eruption due to cimetidine (so-called baboon syndrome). Dermatology 1998: 197: 402-403.
32. Pfeiff B, Pullmann H. Baboon-artiges arzneiexanthem auf heparin. Deutsch Dermatologe 1991: 39: 559-560.
33. Chowdhury M M, Patel G K, Inaloz H S, Holt P J. Hydroxyurea-induced skin disease mimicking the baboon syndrome. Clin Exp Dermatol 1999: 24: 336-337.
34. Barbaud A, Trechot P, Granel F et al. A baboon syndrome induced by intravenous human immunoglobulins: report of a case and immunological analysis. Dermatology 1999: 199: 258-260.
35. De Groot A C, Conemans J M. Systemic allergic contact dermatitis from intravesical instillation of the antitumor antibiotic mitomycin C. Contact Dermatitis 1991: 24: 201-209.
36. Lechner T, Grytzmann B, Baurle G. Hematogenous allergic contact dermatitis after oral administration of nystatin. Mykosen 1987: 30: 143-146.
37. Gordon E. Baboon syndrome caused by Salasate. J Drugs Dermatol 2002: 1: 66.
38. Weiss J M, Mockenhaupt M, Schopf E, Simon J C. Reproducible drug exanthem to terbinafine with characteristic distribution of baboon syndrome. Hautarzt 2001: 52: 1104-1106.
39. Menne T, Weismann K. Hematogenous contact eczema following oral administration of neomycin. Hautarzt 1984: 35: 319-320.
40. Guin J D, Fields P, Thomas K L. Baboon syndrome from i.v. aminophylline in a patient allergic to ethylendiamine. Contact Dermatitis 1999: 40: 170-171.
41. Isaksson M, Ljunggren B. Systemic contact dermatitis from ethylendiamine in an aminophylline preparation presenting as the baboon syndrome. Acta Derm Venereol 2003: 83: 69-70.
42. Gallo R, Parodi A. Baboon syndrome from 5-aminosalicylic acid. Contact Dermatitis 2002: 46: 110.
43. Proske S, Uter W, Schnuch A, Hartschuh W. Severe allergic contact dermatitis with generalized spread due to bufexamac presenting as the 'baboon' syndrome. Dtsch Med Wochenschr 2003: 128: 545-547.
44. Marques C, Faria E, Machado A et al. Allergic contact dermatitis and systemic contact dermatitis from cinchocaine. Contact Dermatitis 1995: 33: 443.
45. Erdmann S M, Sachs B, Merk H F. Systemic contact dermatitis from cinchocaine. Contact Dermatitis 2001: 44: 260-261.
46. Happle R. Paraptic eczema. Why a new name? Hautarzt 1994: 45: 1-3.
47. Ratner J H, Spencer S K, Grainge J M. Cashew nut dermatitis. An example of internal-external contact-type hypersensitivity. Arch Dermatol 1974: 110: 921-923.